173 related articles for article (PubMed ID: 24350356)
1. 21st-century oncology: a tangled web.
Keating P; Cambrosio A
Lancet; 2013 Dec; 382(9909):e45-6. PubMed ID: 24350356
[No Abstract] [Full Text] [Related]
2. The daunting task of modeling response to imatinib therapy in patients with chronic myelogenous leukemia.
Quintás-Cardama A; Kantarjian H; Cortes J
Leuk Lymphoma; 2007 Apr; 48(4):802-4. PubMed ID: 17454640
[No Abstract] [Full Text] [Related]
3. The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia.
Eskazan AE; Elverdi T; Yalniz FF; Salihoglu A; Ar MC; Ongoren Aydin S; Baslar Z; Aydin Y; Tuzuner N; Ozbek U; Soysal T
Leuk Lymphoma; 2014 Dec; 55(12):2935-7. PubMed ID: 24650055
[No Abstract] [Full Text] [Related]
4. Effectiveness of imatinib therapy for sickle cell anemia and chronic myeloid leukemia.
Murphy M; Close J; Lottenberg R; Rajasekhar A
Am J Med Sci; 2014 Mar; 347(3):254-5. PubMed ID: 24553361
[No Abstract] [Full Text] [Related]
5. On the reliability of mitotic count on biopsy samples of gastrointestinal stromal tumors.
Cananzi FC
Eur J Surg Oncol; 2014 Apr; 40(4):486. PubMed ID: 24486076
[No Abstract] [Full Text] [Related]
6. On the reliability of mitotic count on biopsy samples of gastrointestinal stromal tumors.
Ricci R; Chiarello G; Vanella G; Larghi A
Eur J Surg Oncol; 2014 Apr; 40(4):484-5. PubMed ID: 24486075
[No Abstract] [Full Text] [Related]
7. Value of pharmacokinetic studies for patients with gastrointestinal stromal tumors.
De Giorgi U
Future Oncol; 2013 Nov; 9(11):1675-7. PubMed ID: 23862700
[No Abstract] [Full Text] [Related]
8. STI571: a magic bullet?
Verweij J; Judson I; van Oosterom A
Eur J Cancer; 2001 Oct; 37(15):1816-9. PubMed ID: 11576833
[No Abstract] [Full Text] [Related]
9. Imatinib mesylate therapy in chronic myeloid leukaemia: the floodgates opened.
Agarwal MB
J Assoc Physicians India; 2007 Feb; 55():99-100. PubMed ID: 17571737
[No Abstract] [Full Text] [Related]
10. Application of comorbidity indexes at baseline could be useful to predict rates of response in patients with chronic myeloid leukemia treated with imatinib.
Breccia M; Salaroli A; Serrao A; Zacheo I; Saracino R; Alimena G
Leuk Lymphoma; 2014 Jan; 55(1):204-6. PubMed ID: 23586870
[No Abstract] [Full Text] [Related]
11. Kinase inhibitor therapy in CML: it's what's inside that counts.
Eide CA; Druker BJ; O'Hare T
Oncotarget; 2013 Sep; 4(9):1332-3. PubMed ID: 23934763
[No Abstract] [Full Text] [Related]
12. 3. Imatinib therapy in chronic myelogenous leukemia.
Jinnai I
Intern Med; 2007; 46(2):95-7. PubMed ID: 17220607
[No Abstract] [Full Text] [Related]
13. Imatinib (Gleevec) as a paradigm of targeted cancer therapies.
Druker B
Keio J Med; 2010; 59(1):1-3. PubMed ID: 20375651
[No Abstract] [Full Text] [Related]
14. STI571 revolution: can the newer targeted drugs measure up?
Garber K
J Natl Cancer Inst; 2001 Jul; 93(13):970-3. PubMed ID: 11438556
[No Abstract] [Full Text] [Related]
15. Adherence to imatinib therapy in gastrointestinal stromal tumors and chronic myeloid leukemia.
Al-Barrak J; Cheung WY
Support Care Cancer; 2013 Aug; 21(8):2351-7. PubMed ID: 23708821
[TBL] [Abstract][Full Text] [Related]
16. Bosutinib in the treatment of chronic myelogenous leukemia.
Cortes J
Clin Adv Hematol Oncol; 2012 Nov; 10(11):736-7. PubMed ID: 23271260
[No Abstract] [Full Text] [Related]
17. David A. Karnofsky Award lecture. Imatinib as a paradigm of targeted therapies.
Druker BJ
J Clin Oncol; 2003 Dec; 21(23 Suppl):239s-245s. PubMed ID: 14645403
[No Abstract] [Full Text] [Related]
18. Evaluation of regorafenib in colorectal cancer and GIST.
Waddell T; Cunningham D
Lancet; 2013 Jan; 381(9863):273-5. PubMed ID: 23177516
[No Abstract] [Full Text] [Related]
19. [Potential clinical benefit of therapeutic drug monitoring of imatinib in oncology].
Turjap M; Juřica J; Demlová R
Klin Onkol; 2015; 28(2):105-11. PubMed ID: 25882020
[TBL] [Abstract][Full Text] [Related]
20. Management of gastrointestinal stromal tumor: the imatinib era and beyond.
Parikh PM; Gupta S
Indian J Cancer; 2013; 50(1):31-40. PubMed ID: 23713042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
